News
A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...
Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, ...
By December 2023, 12.3% of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM.
A new study has found that the weight-loss drug tirzepatide can help people lose a significant amount of weight and keep it ...
Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results